Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Portfolio

Our investments accelerate growth and stimulate private sector innovation and investment, giving our partners additional tools to effect change and improve lives. We make investments that align with foundation issue areas from vaccine development to education in the United States.

More on the types of investments we make.

Here you can explore our current and past investments, filtered by issue area or investment type.

Adjuvant Global Health Technology Fund

The foundation has committed to further support the Global Health Investment Fund model by investing as an anchor LP in Adjuvant. Adjuvant is a private investment fund focused on late-stage life sciences investments to address global health challenges. The Fund invests Read More


		Affinivax Logo

Affinivax

Affinivax achieves unprecedented levels of immune response and disease protection by streamlining the process of vaccine design and allowing for multiple antigens to be effectively incorporated in a single vaccine.

News Story

Africa Health Fund

The foundation invested in the Africa Health Fund to provide capital to support new approaches to improving the quality and accessibility of private healthcare across the continent.

African Agricultural Capital Fund

The African Agricultural Capital Fund provides growth capital to companies that boost the productivity and profitability of smallholder farmers in East Africa.

Press Release

		AgBiome Logos

AgBiome

AgBiome is focused on discovery and development of biological and transgenic products for crop protection. AgBiome identifies microbes from a wide variety of sources to harness their natural abilities to help crops resist pests and stresses.

Press Release

		AgTech Logo

AgTech Accelerator

The Agtech Accelerator is a start-up incubator based in Research Triangle Park, NC focused on fostering entrepreneurship in agriculture, supported by a syndicate of investors, including ARCH Venture Partners, Flagship Ventures, Hatteras Venture Partners, Bayer CropScience, Syngenta Ventures, and others.

Press Release

		amyris logo

Amyris

The foundation invested in Amyris to support the development of new, low-cost technologies for manufacturing compounds to make semi-synthetic artemisinin that can be used in anti-malaria treatments.

Atreca

Atreca is a biotechnology company that employs its proprietary discovery platform to generate and develop therapeutics based on its ability to rapidly characterize the human adaptive immune response at the single cell level.  The Atreca platform enables the high-throughput phylogenetic Read More

News Story

Avanti Finance

Avanti Finance Private Limited is a Non-Banking Financial Company and financial technology platform in India focused on enabling financial inclusion and sustainable livelihoods through improved access to affordable, livelihoods-purpose credit for unbanked and low-income populations across the country. The foundation Read More

Press Release

		China National Biotec Group

Beijing Bio-Institute Biological Products

Beijing Bio-Institute Biological Products is devoted to the research, development, production, and supply of biological products.

Press Release